Neuphoria Therapeutics Ratios (2020-2026) | NEUP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2020	Jun2021	Dec2021	Jun2022	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
EBT Margin (Quarter)											-291.49%	74.54%	68,970.07%
EBIT Margin (Quarter)											-558.84%	79.85%	36,797.58%
EBITDA Margin (Quarter)											-487.66%	73.78%	58,915.04%
Operating Margin (Quarter)											-558.84%	79.85%	36,797.58%
Net Margin (Quarter)											-293.24%	75.08%	70,491.32%
FCF Margin (Quarter)											-506.72%	76.36%	27,022.48%
Efficiency
Assets Average (Quarter)		21.25M	45.60M	48.10M	37.76M					25.28M	20.54M	24.44M	29.65M	27.97M	31.97M	35.70M
Equity Average (Quarter)		22.48M			31.46M	19.69M	18.36M	18.72M	17.72M	17.28M	15.41M	19.87M	22.50M	15.76M	21.11M	29.56M
Invested Capital (Quarter)	8.31M	36.65M		40.76M	22.15M	17.23M	19.50M	17.95M	17.49M	17.07M	13.75M	26.00M	19.00M	12.51M	29.70M	29.42M
Leverage & Solvency
Equity Ratio (Quarter)	11.61	0.88		0.87	0.77				0.63	0.74	0.76	0.85	0.66	0.46	0.81	0.85
Valuation
Enterprise Value (Quarter)	-3.00M	-22.28M	-29.48M	-24.04M	-12.20M	-8.14M	-10.15M	-8.43M	-12.61M	-8.08M	-4.34M	-17.00M	-14.29M	-13.73M	-22.28M	-19.40M
Return Ratios
Return on Sales (Quarter)											-0.03%	0.01%	7.05%
Return on Capital Employed (Quarter)										-8.78%	-6.22%	57.78%	-0.69%	-9.90%	-8.91%	-49.02%
Return on Invested Capital (Quarter)									0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.00%	-0.01%
Return on Assets (Quarter)										0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%
Return on Equity (Quarter)						0.00%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	-0.01%	0.00%	-0.01%